Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo

This study has been completed.
Information provided by (Responsible Party):
Pfizer Identifier:
First received: May 8, 2012
Last updated: June 7, 2012
Last verified: June 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)